| P50 | author | Beatrice Anfuso | Q53221731 |
| | Caecilia Hc Sukowati | Q82903513 |
| | Claudio Tiribelli | Q41817157 |
| P2093 | author name string | Korri E El-Khobar | |
| | David H Muljono | |
| | Susan I Ie | |
| P2860 | cites work | High serum levels of HDV RNA are predictors of cirrhosis and liver cancer in patients with chronic hepatitis delta | Q21132282 |
| | Re-evaluation of the Carcinogenic Significance of Hepatitis B Virus Integration in Hepatocarcinogenesis | Q21134147 |
| | Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q21534928 |
| | Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. Involvement of basic leucine zipper transcription factors | Q22008465 |
| | Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway | Q24537844 |
| | The enigmatic X gene of hepatitis B virus | Q24561887 |
| | CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection | Q24645322 |
| | Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep) | Q24670052 |
| | Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma | Q26864479 |
| | Natural history of hepatitis C | Q27000737 |
| | ER stress-induced cell death mechanisms | Q27027638 |
| | Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription | Q27469443 |
| | Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis | Q46120182 |
| | Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C. | Q46709785 |
| | Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis | Q53118691 |
| | Efficacy of a mass hepatitis B immunization program after switching to recombinant hepatitis B vaccine: a population-based study in Taiwan | Q57205469 |
| | INFLUENCE OF DELTA INFECTION ON SEVERITY OF HEPATITIS B | Q61618262 |
| | Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China | Q79624691 |
| | Differences of HBV genotypes and hepatocellular carcinoma in Asian countries | Q80603851 |
| | Hepatitis delta virus | Q83927727 |
| | Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis | Q84389486 |
| | Hepatocellular carcinoma: New and emerging risks | Q84403203 |
| | HCV-related hepatocellular carcinoma: From chronic inflammation to cancer | Q37632065 |
| | The cell biology of hepatitis C virus | Q37676598 |
| | Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. | Q37699395 |
| | Molecularly targeted therapy in hepatocellular carcinoma. | Q37725350 |
| | Hepatitis D: clinical features and therapy | Q37749315 |
| | Hepatitis C virus replication cycle | Q37767806 |
| | Ageing, telomeres, senescence, and liver injury. | Q37782468 |
| | Hepatitis C virus: How genetic variability affects pathobiology of disease | Q37825652 |
| | Hepatocellular cancer in the non-cirrhotic liver | Q37838585 |
| | Hepatitis B virus X gene and hepatocarcinogenesis. | Q37885837 |
| | Role of hepatitis C virus genotype 3 in liver fibrosis progression--a systematic review and meta-analysis | Q37944951 |
| | New insight in the pathobiology of hepatitis B virus infection | Q38002792 |
| | Treatment of HBV related cirrhosis | Q38071404 |
| | Hepatitis C virus diversity and hepatic steatosis | Q38072721 |
| | HCV and oxidative stress in the liver. | Q38077447 |
| | Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections | Q38098807 |
| | Hepatitis B virus gene mutations and hepatocarcinogenesis | Q38148250 |
| | Is genotype 3 of the hepatitis C virus the new villain? | Q38155123 |
| | Hepatitis B virus-induced hepatocellular carcinoma: the role of the virus x protein. | Q38167814 |
| | 'Liver let die': oxidative DNA damage and hepatotropic viruses | Q38185292 |
| | New hepatitis C therapies: the toolbox, strategies, and challenges | Q38196150 |
| | Orchestration of hepatocellular carcinoma development by diverse liver cancer stem cells | Q38197503 |
| | The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review. | Q38217657 |
| | Genotypes and genetic variability of hepatitis B virus | Q38230753 |
| | The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. | Q38246712 |
| | Hepatocellular carcinoma epidemiology | Q38254688 |
| | Pathogenesis of hepatocellular carcinoma according to aetiology | Q38254705 |
| | Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy. | Q38321507 |
| | Dissection of cell context-dependent interactions between HBx and p53 family members in regulation of apoptosis: a role for HBV-induced HCC. | Q38330795 |
| | Animal models of chronic hepatitis delta virus infection host-virus immunologic interactions | Q38357110 |
| | Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis. | Q38444423 |
| | Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis | Q38899314 |
| | Global estimates of cancer prevalence for 27 sites in the adult population in 2008. | Q38920305 |
| | The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm | Q39213684 |
| | Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case-control study in The Gambia | Q39457696 |
| | Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma | Q44395085 |
| | Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1. | Q44507323 |
| | Thirty-year outcomes of the national hepatitis B immunization program in Taiwan | Q44712948 |
| | Mechanism of telomere shortening by oxidative stress | Q44972990 |
| | Seroprevalence of hepatitis B virus infection among children and adolescents in Singapore, 2008-2010. | Q45022308 |
| | Role of cell-cycle turnover and oxidative stress in telomere shortening and cellular senescence in patients with chronic hepatitis C. | Q45253874 |
| | Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis. | Q45361136 |
| | Hepatitis B Virus X (HBx) Induces Tumorigenicity of Hepatic Progenitor Cells in 3,5–Diethoxycarbonyl–1,4–Dihydrocollidine–Treated HBx Transgenic Mice | Q45363162 |
| | Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus | Q45385130 |
| | Hepatitis B virus-X protein recruits histone deacetylase 1 to repress insulin-like growth factor binding protein 3 transcription | Q45389152 |
| | Impact of chronic hepatitis C and/or D on liver fibrosis severity in patients co-infected with HIV and hepatitis B virus | Q45399150 |
| | Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients | Q45399173 |
| | Pin1-HBx interaction: a step toward understanding the significance of hepatitis B virus genotypes in hepatocarcinogenesis. | Q45401325 |
| | Longer survival of liver transplant recipients with hepatitis virus coinfections | Q45405259 |
| | Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. | Q45699015 |
| | Precore and core promoter mutations, hepatitis B virus DNA levels and progressive liver injury in chronic hepatitis B. | Q45731371 |
| | Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1 | Q27471632 |
| | Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus NS5B RNA-dependent RNA polymerase | Q27472746 |
| | Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients | Q27477975 |
| | Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C | Q27477981 |
| | Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog | Q27487860 |
| | HCV Induces Oxidative and ER Stress, and Sensitizes Infected Cells to Apoptosis in SCID/Alb-uPA Mice | Q27487963 |
| | EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma | Q27860783 |
| | Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 |
| | Sorafenib in advanced hepatocellular carcinoma | Q27861075 |
| | Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators | Q28267500 |
| | Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma | Q28284012 |
| | Hepatocellular carcinoma in cirrhosis: incidence and risk factors | Q28290048 |
| | Hepatocellular carcinoma: epidemiology and molecular carcinogenesis | Q28306363 |
| | Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection | Q28368984 |
| | HCV causes chronic endoplasmic reticulum stress leading to adaptation and interference with the unfolded protein response | Q28477137 |
| | Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas | Q28649881 |
| | Hepatocellular carcinoma | Q29615765 |
| | EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection | Q29615868 |
| | Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence | Q29616009 |
| | Hepatocellular carcinoma | Q29616359 |
| | Chronic hepatitis B: update 2009 | Q29617409 |
| | Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma | Q29617918 |
| | Mechanisms of hepatic fibrogenesis | Q29619336 |
| | Primary liver cancer: worldwide incidence and trends | Q29620133 |
| | Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein | Q29620682 |
| | The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology | Q30447686 |
| | Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. | Q31040495 |
| | Genetic study of hepatitis B virus in Indonesia reveals a new subgenotype of genotype B in east Nusa Tenggara | Q33332484 |
| | Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication | Q33717232 |
| | Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma | Q33723810 |
| | Molecular biology of liver cancer stem cells | Q33756006 |
| | Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource | Q33777199 |
| | Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions | Q33780105 |
| | Ethnogeographical structure of hepatitis B virus genotype distribution in Indonesia and discovery of a new subgenotype, B9 | Q33819764 |
| | Hepatitis B virus biology | Q33855246 |
| | Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner | Q33905849 |
| | The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma | Q36096454 |
| | Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib. | Q36247123 |
| | Decreased mitochondrial deoxyribonucleic acid and increased oxidative damage in chronic hepatitis C. | Q36285802 |
| | HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV. | Q36399139 |
| | Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis | Q36545096 |
| | Treating viral hepatitis C: efficacy, side effects, and complications | Q36564615 |
| | The identification of stem cells in human liver diseases and hepatocellular carcinoma | Q36672523 |
| | Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic liver injury | Q36800154 |
| | Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer | Q36812745 |
| | Molecular targeted therapies in hepatocellular carcinoma | Q37003665 |
| | Mechanisms of fibrogenesis | Q37068410 |
| | Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis | Q37289608 |
| | Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes | Q37356991 |
| | Hepatitis C virus-induced hepatocarcinogenesis. | Q37527272 |
| | Experimental mouse models for hepatocellular carcinoma research | Q37574072 |
| | Hepatic oval cell lines generate hepatocellular carcinoma following transfection with HBx gene and treatment with aflatoxin B1 in vivo | Q39494099 |
| | Hepatitis C virus core protein activates Wnt/β-catenin signaling through multiple regulation of upstream molecules in the SMMC-7721 cell line | Q39588175 |
| | Hepatitis C Virus Inhibits DNA Damage Repair through Reactive Oxygen and Nitrogen Species and by Interfering with the ATM-NBS1/Mre11/Rad50 DNA Repair Pathway in Monocytes and Hepatocytes | Q39639979 |
| | Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis | Q39804511 |
| | Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes | Q39870084 |
| | Interaction of hepatitis C virus core protein with Hsp60 triggers the production of reactive oxygen species and enhances TNF-alpha-mediated apoptosis | Q39876832 |
| | Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A. | Q39907053 |
| | Hepatitis C virus NS3/4A protein interacts with ATM, impairs DNA repair and enhances sensitivity to ionizing radiation. | Q40068992 |
| | Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein | Q40149729 |
| | Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis | Q40154756 |
| | Activation of the ER stress gene gadd153 by hepatitis C virus sensitizes cells to oxidant injury | Q40157434 |
| | Non-structural protein 4A of Hepatitis C virus accumulates on mitochondria and renders the cells prone to undergoing mitochondria-mediated apoptosis | Q40270295 |
| | Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion | Q40421534 |
| | Activation of RB/E2F signaling pathway is required for the modulation of hepatitis C virus core protein-induced cell growth in liver and non-liver cells. | Q40513204 |
| | Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. | Q40526270 |
| | Comprehensive analysis of mutations in the hepatitis delta virus genome based on full-length sequencing in a nationwide cohort study and evolutionary pattern during disease progression | Q41471888 |
| | Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. | Q41486355 |
| | Seroepidemiology and clinical features of hepatitis delta among HBsAg carriers: a study from Hepatitis Clinic of Iranian Blood Transfusion Organization | Q41591618 |
| | Hepatitis B virus core promoter mutations in patients with chronic hepatitis B and hepatocellular carcinoma in bucharest, romania | Q41615602 |
| | Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance | Q41637137 |
| | An adolescent female having hepatocellular carcinoma associated with hepatitis B virus genotype H with a deletion mutation in the pre-S2 region | Q41639181 |
| | Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice | Q41757834 |
| | Gene expression analysis in HBV transgenic mouse liver: a model to study early events related to hepatocarcinogenesis | Q41939991 |
| | Expression of EpCAM increases in the hepatitis B related and the treatment-resistant hepatocellular carcinoma. | Q42181540 |
| | Analysis on the clinical features of 507 HDV-infected patients | Q42202348 |
| | Infected hematopoietic stem cells and with integrated HBV DNA generate defective T cells in chronic HBV infection patients | Q42224468 |
| | Hepatitis C virus-induced activation of β-catenin promotes c-Myc expression and a cascade of pro-carcinogenetic events | Q42288483 |
| | Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. | Q42436412 |
| | Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. | Q42512911 |
| | HCV Infection and Metabolic Syndrome: Which Is the Chicken and Which Is the Egg? | Q42979793 |
| | Hepatitis C Virus-Associated Primary Hepatocellular Carcinoma in Non-cirrhotic Patients | Q42981225 |
| | Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription | Q42981463 |
| | Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study | Q42981575 |
| | Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis | Q42987117 |
| | Hepatitis C virus induces oxidative stress, DNA damage and modulates the DNA repair enzyme NEIL1. | Q42994110 |
| | Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production | Q42995051 |
| | The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients | Q42997190 |
| | Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection | Q43000815 |
| | Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis | Q43031864 |
| | Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study | Q43039760 |
| | HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis | Q43040452 |
| | Oxidative stress and hepatitis C viral infection | Q43744236 |
| | Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C. | Q43752990 |
| | Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas | Q43857388 |
| | Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. | Q43905234 |
| | Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. | Q44135004 |
| | Meta‐analysis: the association of hepatitis B virus genotypes and hepatocellular carcinoma | Q44138158 |
| | Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease | Q44148647 |
| | Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. | Q33933056 |
| | Hepatitis B virus genotypes | Q33985572 |
| | Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). | Q33998195 |
| | Hepatitis D virus: an update | Q34024141 |
| | Geographical and genetic diversity of the human hepatitis B virus | Q34098789 |
| | Cancer stem cells generated by alcohol, diabetes, and hepatitis C virus | Q34155181 |
| | Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers | Q34213628 |
| | Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial | Q34225721 |
| | Novel point and combo-mutations in the genome of hepatitis B virus-genotype D: characterization and impact on liver disease progression to hepatocellular carcinoma | Q34343960 |
| | The emerging role of hepatitis B virus pre-S2 deletion mutant proteins in HBV tumorigenesis. | Q34354947 |
| | Global distribution and prevalence of hepatitis C virus genotypes | Q34431175 |
| | Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level | Q34481474 |
| | Viral hepatitis and liver cancer: the case of hepatitis C. | Q34568619 |
| | Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma. | Q34574971 |
| | Viral hepatocarcinogenesis | Q34617749 |
| | Epidemiological, clinical and histological characteristics of HBV/HDV co-infection: a retrospective cross-sectional study in Guangdong, China | Q34757956 |
| | Hepatitis B virus genotype C takes a more aggressive disease course than hepatitis B virus genotype B in hepatitis B e antigen-positive patients | Q34773725 |
| | Hepatitis C virus NS2 protein triggers endoplasmic reticulum stress and suppresses its own viral replication | Q34797179 |
| | Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? | Q34988085 |
| | Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-kappaB and STAT-3. | Q34989433 |
| | MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells | Q34991081 |
| | Viral hepatitis: past and future of HBV and HDV. | Q35045045 |
| | Prevention of hepatitis B. | Q35164249 |
| | Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with HBV-associated liver cirrhosis in China | Q35173805 |
| | Distinct distribution pattern of hepatitis B virus genotype C and D in liver tissue and serum of dual genotype infected liver cirrhosis and hepatocellular carcinoma patients | Q35208134 |
| | Chronic hepatitis B and liver cancer risks among Asian immigrants in New York City: Results from a large, community-based screening, evaluation, and treatment program | Q35215610 |
| | Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts | Q35531664 |
| | Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview | Q35541482 |
| | Is Hepatitis C Virus Carcinogenic? | Q35576656 |
| | Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2. | Q35609669 |
| | Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan. | Q35612669 |
| | Hepatitis B virus genotypes and hepatocellular carcinoma in Japan | Q35612676 |
| | Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update | Q35706189 |
| | The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. | Q35864702 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| | virology | Q7215 |
| P304 | page(s) | 1497-1512 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma | |
| P478 | volume | 22 | |